Vice President, Inflammatory and Immune Disease Biomarker Development

Apogee Therapeutics(21 days ago)

HybridFull TimeExecutive$320,000 - $355,000Research & Translational Medicine

About this role

Apogee Therapeutics is hiring a Vice President to lead biomarker development for inflammatory and immune diseases, with emphasis on atopic dermatitis, asthma, COPD, and EOE. The role reports to the SVP of Research and Translational Medicine and drives biomarker strategy across late-stage development through Phase 3 and BLA readiness. This leader will build and guide internal teams while managing external collaborators to advance biomarker programs that support clinical and regulatory goals.

View Original Listing

Required Skills

Biomarker Strategy
Biomarker Development
Translational Medicine
Clinical Development
Phase 3 Trials
BLA Readiness
Regulatory Strategy
Antibody Development
In Vitro Studies
In Vivo Studies

+8 more

Qualifications

About Apogee Therapeutics

apogeetherapeutics.com

Apogee Therapeutics is a clinical-stage biotechnology company developing differentiated biologics for immunological and inflammatory diseases. The company focuses on high-unmet-need conditions including atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other I&I disorders. Apogee advances therapeutic candidates through clinical development with the goal of delivering best‑in‑class treatments for patients with inflammatory and immune-mediated diseases.